We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Canada's Generics Export Program Falters Amid Litigation Fears

Law360 (November 26, 2004, 12:00 AM EST) -- Canadian generic drug makers are opting out of the country’s trailblazing efforts to supply developing countries with patented drugs, blaming excessive safeguards for patent holders under the new law, according to a published report.

Drug makers are choosing not to participate in the government's generic export scheme due to the lack of financial incentives, Jeff Connell of the Canadian Generic Pharmaceutical Association (CGPA) told the Inter Press Service.

In May, Canada passed the Jean Chrétien Pledge to Africa Act, named after the country’s former Prime Minister,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.